SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Achiron, A.
Right arrow Articles by Rotstein, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Achiron, A.
Right arrow Articles by Rotstein, Z.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Longitudinal disability curves for predicting the course of relapsing-remitting multiple sclerosis

Anat Achiron

Multiple Sclerosis Center, Sheba Medical Center, Tel-Hashomer, Israel, affiliated to Tel-Aviv University, Sackler School of Medicine, Israel, achiron{at}post.tau.ac.il

Yoram Barak

Multiple Sclerosis Center, Sheba Medical Center, Tel-Hashomer, Israel, affiliated to Tel-Aviv University, Sackler School of Medicine, Israel

Zeev Rotstein

Multiple Sclerosis Center, Sheba Medical Center, Tel-Hashomer, Israel, affiliated to Tel-Aviv University, Sackler School of Medicine, Israel

Background: Multiple sclerosis (MS) is a lifelong disease affecting young adults that ultimately can lead to significant neurological disability. Identifying the rate of progression of disability for an individual patient early in the disease process can influence treatment decisions as well as enable monitoring of the disease overtime. Objective: The aims of the present study were to develop longitudinal disability curves to assess disease progression in patients with relapsing -remitting MS. The construction of these disability curves was based on the mean yearly Expanded Disability Status Scale (EDSS) scores, represented as a major percentile group. To determine their predictive ability, validation of the percentile curves was performed. Methods: Using the Multiple Sclerosis C enter computerized database of 1540 patients’ records, we identified 1317 subjects with a definite MS and a relapsing-remitting disease course. Longitudinal disability curves were constructed for a subgroup of relapsing-remitting patients (n=1001) with consecutive (3-6 months) EDSS assessments for a period of up to 10 years since onset. The constructed disability curves were then validated in an additional subgroup of relapsing - remitting MS patients (n=268) with continuous follow-up visits for a period of 10 years. Results: Statistical procedures using parametric and nonparametric regression procedures were applied to the data in two stages. In the first stage, selected major percentiles were generated for up to 10 years from disease onset with a variety of parametric procedures including moving averages. In the second stage, the empirical percentiles were smoothed to obtain the final disability progression curves. The log-rank test for equality demonstrated a significant adjustment between the initial percentile assignment and disability progression (P B-0.001). Life table analysis demonstrated that the probability of deviating from the initially assigned percentile to a higher percentile over time, representing more severe disability than expected, is in the range of 6.5% for the 50th percentile to 10.4% for the 75th percentile. Conclusion: Longitudinal disability curves can be used in MS to assess individual patient disability, can contribute to the overall clinical impression of disease progression and can add to the evaluation of immunomodulating treatment effects overtime.

Key Words: disability • EDSS • multiple sclerosis • progression

Multiple Sclerosis, Vol. 9, No. 5, 486-491 (2003)
DOI: 10.1191/1352458503ms945oa


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
NeurologyHome page
S. A. Gauthier, M. Mandel, C.R.G. Guttmann, B. I. Glanz, S. J. Khoury, R. A. Betensky, and H. L. Weiner
Predicting short-term disability in multiple sclerosis
Neurology, June 12, 2007; 68(24): 2059 - 2065.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
A. Langer-Gould, R. A. Popat, S. M. Huang, K. Cobb, P. Fontoura, M. K. Gould, and L. M. Nelson
Clinical and Demographic Predictors of Long-term Disability in Patients With Relapsing-Remitting Multiple Sclerosis: A Systematic Review
Arch Neurol, December 1, 2006; 63(12): 1686 - 1691.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. A. Marrie, G. Cutter, T. Tyry, T. Vollmer, and D. Campagnolo
Does multiple sclerosis-associated disability differ between races?
Neurology, April 25, 2006; 66(8): 1235 - 1240.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
T. Berger, F. Deisenhammer, J. C. Alvarez-Cermeno, J. Masjuan, L. M. Villar, B.K. Kleinschmidt-DeMasters, K. L. Tyler, A. Langer-Gould, S. W. Atlas, and D. Pelletier
Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis.
N. Engl. J. Med., October 20, 2005; 353(16): 1744 - 1746.
[Full Text] [PDF]



Advertisement